These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 1839621)
1. Cardioprotective effects of KRN2391 and nicorandil on ischemic dysfunction in perfused rat heart. Ohta H; Jinno Y; Harada K; Ogawa N; Fukushima H; Nishikori K Eur J Pharmacol; 1991 Nov; 204(2):171-7. PubMed ID: 1839621 [TBL] [Abstract][Full Text] [Related]
2. Effects of KRN2391, nicorandil and diltiazem on the changes in the electrocardiogram caused by endothelin-1 in anaesthetized rats. Harada K; Miwa A; Kaneta S; Izawa T; Fukushima H; Ogawa N Br J Pharmacol; 1993 Jul; 109(3):679-84. PubMed ID: 7689399 [TBL] [Abstract][Full Text] [Related]
3. Comparison of KRN2391 with nicorandil and nifedipine on canine coronary blood flow: antagonism by glibenclamide. Ogawa N; Fukata Y; Kaneta S; Jinno Y; Fukushima H; Nishikori K J Cardiovasc Pharmacol; 1992 Jul; 20(1):11-7. PubMed ID: 1383619 [TBL] [Abstract][Full Text] [Related]
4. Nicorandil improves postischemic contractile function independently of direct myocardial effects. Grover GJ; Sleph PG; Parham CS J Cardiovasc Pharmacol; 1990 May; 15(5):698-705. PubMed ID: 1692928 [TBL] [Abstract][Full Text] [Related]
5. Effects of glibenclamide and nicorandil on cardiac function during ischemia and reperfusion in isolated perfused rat hearts. Mitani A; Kinoshita K; Fukamachi K; Sakamoto M; Kurisu K; Tsuruhara Y; Fukumura F; Nakashima A; Tokunaga K Am J Physiol; 1991 Dec; 261(6 Pt 2):H1864-71. PubMed ID: 1836311 [TBL] [Abstract][Full Text] [Related]
6. Vasorelaxant mechanism of KRN2391 and nicorandil in porcine coronary arteries of different sizes. Miwa A; Kaneta S; Motoki K; Jinno Y; Kasai H; Okada Y; Fukushima H; Ogawa N Br J Pharmacol; 1993 Jul; 109(3):632-6. PubMed ID: 8358563 [TBL] [Abstract][Full Text] [Related]
7. Effects of K+ channel openers on ischemic dysfunction and metabolic disturbance in isolated perfused rat heart. Ohta H; Nakazawa H; Jinno Y; Harada K; Ogawa N; Miwa A; Nishikori K Eur J Pharmacol; 1993 Feb; 231(3):323-30. PubMed ID: 8449225 [TBL] [Abstract][Full Text] [Related]
8. Dissimilarity in the mechanisms of action of KRN2391, nicorandil and cromakalim in canine renal artery. Kasai H; Fukata Y; Harada K; Fukushima H; Ogawa N J Pharm Pharmacol; 1993 Mar; 45(3):222-4. PubMed ID: 8097782 [TBL] [Abstract][Full Text] [Related]
9. Hemodynamic profile of KRN2391, a novel vasodilator, in anesthetized dogs. Ogawa N; Jinno Y; Kaneta S; Harada K; Fukata Y; Fukushima H J Cardiovasc Pharmacol; 1993 Jun; 21(6):874-82. PubMed ID: 7687711 [TBL] [Abstract][Full Text] [Related]
10. Effect of KRN2391, a novel vasodilator, on various experimental anginal models in rats. Harada K; Fukata Y; Miwa A; Kaneta S; Fukushima H; Ogawa N Jpn J Pharmacol; 1993 Sep; 63(1):35-9. PubMed ID: 8271529 [TBL] [Abstract][Full Text] [Related]
11. Activation by KRN2391 and nicorandil of glibenclamide-sensitive K+ channels in Xenopus oocytes. Sakuta H; Okamoto K Eur J Pharmacol; 1993 Feb; 244(3):277-83. PubMed ID: 8458402 [TBL] [Abstract][Full Text] [Related]
12. Effect of KRN2391 on venous return: comparison with other vasodilators. Kaneta S; Jinno Y; Miwa A; Fukushima H; Ogawa N J Cardiovasc Pharmacol; 1993 Jul; 22(1):82-8. PubMed ID: 7690101 [TBL] [Abstract][Full Text] [Related]
13. Mechanism of action of KRN2391 in canine coronary vascular bed. Fukata Y; Kaneta S; Okada Y; Yokoyama T; Jinno Y; Fukushima H; Ogawa N Jpn J Pharmacol; 1993 Nov; 63(3):305-11. PubMed ID: 8107323 [TBL] [Abstract][Full Text] [Related]
14. Comparative cardiovascular effects of KRN2391 and other coronary vasodilators in anesthetized open-chest dogs. Ogawa N; Kaneta S; Jinno Y; Kasai H; Nishikori K; Fukushima H Arch Int Pharmacodyn Ther; 1992; 318():36-46. PubMed ID: 1463370 [TBL] [Abstract][Full Text] [Related]
15. Mechanism of action of KRN2391, a novel vasodilator, in canine mesenteric artery. Ogawa N; Fukata Y; Kaneta S; Jinno Y; Miwa A; Fukushima H Jpn J Pharmacol; 1993 Apr; 61(4):303-9. PubMed ID: 8320876 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological analysis of the effect of KRN2391 on coronary vasculature in perfused rat heart. Miwa A; Jinno Y; Yokoyama T; Izawa T; Ogawa N Gen Pharmacol; 1994 May; 25(3):471-4. PubMed ID: 7926593 [TBL] [Abstract][Full Text] [Related]
17. Infarct size-reducing effect of nicorandil is mediated by the KATP channel but not by its nitrate-like properties in dogs. Mizumura T; Nithipatikom K; Gross GJ Cardiovasc Res; 1996 Aug; 32(2):274-85. PubMed ID: 8796114 [TBL] [Abstract][Full Text] [Related]
18. Effects of glibenclamide and nicorandil in post-ischaemic contractile dysfunction of perfused hearts in normotensive and spontaneously hypertensive rats. Nakagawa C; Asayama J; Tatsumi T; Matoba S; Kobara M; Tanaka T; Ohta B; Kawahara A; Tsuruyama K; Katamura M; Nakagawa M J Hypertens; 1996 Jul; 14(7):921-6. PubMed ID: 8818933 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the anti-vasoconstrictor effects of a novel vasodilator KRN2391, nicorandil and nifedipine on isolated porcine large coronary artery. Kasai H; Jinno Y; Kaneta S; Tanaka Y; Fukushima H; Izawa T; Ogawa N Arch Int Pharmacodyn Ther; 1993; 321():63-71. PubMed ID: 8323417 [TBL] [Abstract][Full Text] [Related]
20. Nicorandil: differential contribution of K+ channel opening and guanylate cyclase stimulation to its vasorelaxant effects on various endothelin-1-contracted arterial preparations. Comparison to aprikalim (RP 52891) and nitroglycerin. Borg C; Mondot S; Mestre M; Cavero I J Pharmacol Exp Ther; 1991 Nov; 259(2):526-34. PubMed ID: 1682478 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]